149 related articles for article (PubMed ID: 1665307)
1. Potential use of selective phosphodiesterase inhibitors in the treatment of asthma.
Murray KJ; Eden RJ; England PJ; Dolan J; Grimsditch DC; Stutchbury CA; Patel B; Reeves ML; Worby A; Torphy TJ
Agents Actions Suppl; 1991; 34():27-46. PubMed ID: 1665307
[TBL] [Abstract][Full Text] [Related]
2. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
Ellis JL; Conanan ND
J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
Howell RE; Sickels BD; Woeppel SL
J Pharmacol Exp Ther; 1993 Feb; 264(2):609-15. PubMed ID: 8437112
[TBL] [Abstract][Full Text] [Related]
4. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
5. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ
J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea-pig.
Turner NC; Dolan JS; Grimsditch D; Lamb J; Worby A; Murray KJ; Coates WJ; Warrington BH
Br J Pharmacol; 1994 Apr; 111(4):1198-204. PubMed ID: 8032606
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase-IV inhibition, respiratory muscle relaxation and bronchodilation by WAY-PDA-641.
Heaslip RJ; Lombardo LJ; Golankiewicz JM; Ilsemann BA; Evans DY; Sickels BD; Mudrick JK; Bagli J; Weichman BM
J Pharmacol Exp Ther; 1994 Feb; 268(2):888-96. PubMed ID: 8114002
[TBL] [Abstract][Full Text] [Related]
9. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
Shafiee-Nick R; Pyne NJ; Furman BL
Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
[TBL] [Abstract][Full Text] [Related]
10. Zardaverine: a cyclic AMP specific PDE III/IV inhibitor.
Schudt C; Winder S; Eltze M; Kilian U; Beume R
Agents Actions Suppl; 1991; 34():379-402. PubMed ID: 1665311
[TBL] [Abstract][Full Text] [Related]
11. Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors.
Lagente V; Hichami A; Boichot E; Martins MA; Silva PM
Allerg Immunol (Paris); 1995 Feb; 27(2):34-9. PubMed ID: 7710653
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site.
Barnette MS; Grous M; Cieslinski LB; Burman M; Christensen SB; Torphy TJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1396-402. PubMed ID: 7791113
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
[TBL] [Abstract][Full Text] [Related]
14. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB
J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523
[TBL] [Abstract][Full Text] [Related]
15. The in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4.
Turner CR; Cohan VL; Cheng JB; Showell HJ; Pazoles CJ; Watson JW
J Pharmacol Exp Ther; 1996 Sep; 278(3):1349-55. PubMed ID: 8819522
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors.
Undem BJ; Meeker SN; Chen J
J Pharmacol Exp Ther; 1994 Nov; 271(2):811-7. PubMed ID: 7965800
[TBL] [Abstract][Full Text] [Related]
17. Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus.
Cortijo J; Bou J; Beleta J; Cardelús I; Llenas J; Morcillo E; Gristwood RW
Br J Pharmacol; 1993 Feb; 108(2):562-8. PubMed ID: 8383567
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines.
Sawanishi H; Suzuki H; Yamamoto S; Waki Y; Kasugai S; Ohya K; Suzuki N; Miyamoto K; Takagi K
J Med Chem; 1997 Sep; 40(20):3248-53. PubMed ID: 9379444
[TBL] [Abstract][Full Text] [Related]
19. Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.
Alvarez R; Sette C; Yang D; Eglen RM; Wilhelm R; Shelton ER; Conti M
Mol Pharmacol; 1995 Oct; 48(4):616-22. PubMed ID: 7476886
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition by selective phosphodiesterase inhibitors of antigen, LTC4 and histamine-induced contraction of guinea-pig isolated trachea.
Planquois JM; Ruffin-Morin Y; Lagente V; Payne AN; Dahl SG
Pulm Pharmacol; 1996 Aug; 9(4):251-8. PubMed ID: 9160414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
